UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002022 |
|---|---|
| Receipt number | R000002468 |
| Scientific Title | Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent pancreatic cancer to be refractory to chemotherapy by using new tumor antigen KIF20A and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularization |
| Date of disclosure of the study information | 2009/05/31 |
| Last modified on | 2015/06/01 14:09:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/05/31 23:23:35 | ||
| 2 | Update | 2009/09/07 15:51:14 | Public title |
|
| 3 | Update | 2009/09/07 15:52:43 | Narrative objectives1 |
|
| 4 | Update | 2009/09/07 16:02:29 | Interventions/Control_1 |
|
| 5 | Update | 2009/09/07 16:03:39 | Recruitment status |
|
| 6 | Update | 2009/12/21 15:38:24 | Blinding |
|
| 7 | Update | 2012/03/06 20:15:28 | Last follow-up date |
|
| 8 | Update | 2012/12/03 15:48:09 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 9 | Update | 2012/12/03 15:49:15 | Publication of results |
|
| 10 | Update | 2015/06/01 14:08:23 | Email Last name of contact person Last name of contact person |
|
| 11 | Update | 2015/06/01 14:09:03 | Recruitment status |
